摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-(2-cyclopropylvinyl)thiophene | 1313483-42-9

中文名称
——
中文别名
——
英文名称
(E)-2-(2-cyclopropylvinyl)thiophene
英文别名
(E)-1-(2-thienyl)-2-cyclopropylethene;2-[(E)-2-cyclopropylethenyl]thiophene
(E)-2-(2-cyclopropylvinyl)thiophene化学式
CAS
1313483-42-9
化学式
C9H10S
mdl
——
分子量
150.244
InChiKey
MEJZRLBGOPEEJP-AATRIKPKSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    10
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    28.2
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    2,3-二氯-5,6-二氰基-1,4-苯醌 作用下, 以 乙腈 为溶剂, 以19 mg的产率得到(E)-2-(2-cyclopropylvinyl)thiophene
    参考文献:
    名称:
    Stereodivergent Zweifel Olefination and its Mechanistic Dichotomy
    摘要:
    摘要利用携带两种不同反应性 π-系统的硼酸盐配合物实现了全选择性 Zweifel 烯化反应,从而以良好的收率和高达 100 % 的立体选择性合成了乙烯基杂环戊烯和共轭 1,3 二烯,这一点迄今为止仍未得到探索。最重要的是,我们报告了在相同条件下不同杂环戊烯与 Z-乙烯基杂环戊烯前所未有的形成过程。密度泛函理论(DFT)研究揭示了烯烃和杂环戊烯活化后 1,2 迁移分别导致 E 或 Z 乙烯基杂环戊烯的机理二分法。我们还报告了通过使用 2,3-二氯-5,6-二氰基-1,4-苯醌(DDQ)作为亲电子体,实现了一种之前未知的立体选择性逆转。由于烯烃的位点选择性活化存在巨大挑战,使用携带两种不同烯烃的硼酸酯复合物进行 Zweifel 烯化反应的研究以前从未进行过。我们已经解决了这一问题,并报告了用于立体选择性合成 1,3 二烯的烯烃位点选择性活化。
    DOI:
    10.1002/anie.202309136
点击查看最新优质反应信息

文献信息

  • Novel antifungal agent containing heterocyclic compound
    申请人:Nakamoto Kazutaka
    公开号:US20070105943A1
    公开(公告)日:2007-05-10
    The present invention provides an antifungal agent represented by the formula: [wherein A 1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X 1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A 1 may have 1 to 3 substituents, and E has one or two substituents].
    本发明提供了一种抗真菌剂,其表示为以下式子: [其中A1表示一个3-吡啶基团,可能具有取代基,喹啉基团,可能具有取代基或类似物;X1表示由公式—NH—C(═O)—,由公式—C(═O)—NH—或类似物表示的基团;E表示呋喃基团,噻吩基团,吡咯基团,苯基团,吡啶基团,四唑基团,噻唑基团或吡唑基团;但A1可能具有1到3个取代基,E具有一个或两个取代基。]
  • Novel Antimalarial Agent Containing Heterocyclic Compound
    申请人:Nakamoto Kazutaka
    公开号:US20090227799A1
    公开(公告)日:2009-09-10
    Disclosed is an antimalarial agent containing a compound represented by the formula: [wherein A 1 represents a 3-pyridyl group that may have a substituent, a 6-quinolyl group that may have a substituent, or the like; X 1 represents a group represented by the formula —C(═O)—NH— or the like; E represents a furyl group, a thienyl group or a phenyl group; with the proviso that A 1 may have one to three substituents, and E has one of two substituents] or a salt thereof or hydrates thereof.
    揭示了一种抗疟疾剂,其包含由下式表示的化合物: [其中A1表示一个3-吡啶基团,可以有取代基,一个6-喹啉基团,可以有取代基或类似物;X1表示一个由公式-C(═O)-NH-或类似物表示的基团;E表示一个呋喃基团,噻吩基团或苯基团;但前提是A1可以有1到3个取代基,E有两个取代基之一]或其盐或合物。
  • NOVEL ANTIFUNGAL AGENT CONTAINING HETEROCYCLIC COMPOUND
    申请人:NAKAMOTO Kazutaka
    公开号:US20110195999A1
    公开(公告)日:2011-08-11
    The present invention provides an antifungal agent represented by the formula: wherein A 1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X 1 represents a group represented by the formula —NH—C(═O)—, a group represented by the formula —C(═O)—NH—, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A 1 may have 1 to 3 substituents, and E has one or two substituents.
    本发明提供一种抗真菌剂,其化学式如下: 其中,A1代表3-吡啶基,可以有取代基,喹啉基,也可以有取代基等;X1代表由公式—NH—C(═O)—,由公式—C(═O)—NH—等表示的基团;E代表呋喃基,噻吩基,吡咯基,苯基,吡啶基,四唑基,噻唑基或吡唑基;但要求A1可能有1到3个取代基,E有1或2个取代基。
  • NOVEL ANTIFUNGAL AGENT COMPRISING HETEROCYCLIC COMPOUND
    申请人:Eisai Co., Ltd.
    公开号:EP1669348A1
    公开(公告)日:2006-06-14
    The present invention provides an antifungal agent represented by the formula: [wherein A1 represents a 3-pyridyl group which may have a substituent, a quinolyl group which may have a substituent, or the like; X1 represents a group represented by the formula -NH-C(=O)-, a group represented by the formula -C(=O)-NH-, or the like; E represents a furyl group, a thienyl group, a pyrrolyl group, a phenyl group, a pyridyl group, a tetrazolyl group, a thiazolyl group or a pyrazolyl group; with the proviso that A1 may have 1 to 3 substituents, and E has one or two substituents].
    本发明提供了一种由式表示的抗真菌剂: [其中A1代表可具有取代基的3-吡啶基、可具有取代基的喹啉基或类似基团;X1代表由式-NH-C(=O)-代表的基团、由式-C(=O)-NH-代表的基团或类似基团;E 代表呋喃基、噻吩基、吡咯基、苯基、吡啶基、四唑基、噻唑基或吡唑基;但 A1 可具有 1 至 3 个取代基,E 具有 1 或 2 个取代基]。
  • NOVEL ANTIMALARIA AGENT CONTAINING HETEROCYCLIC COMPOUND
    申请人:Eisai R&D Management Co., Ltd.
    公开号:EP1782811A1
    公开(公告)日:2007-05-09
    Disclosed is an antimalarial agent containing a compound represented by the formula: [wherein A1 represents a 3-pyridyl group that may have a substituent, a 6-quinolyl group that may have a substituent, or the like; X1 represents a group represented by the formula -C(=O)-NH- or the like; E represents a furyl group, a thienyl group or a phenyl group; with the proviso that A1 may have one to three substituents, and E has one of two substituents] or a salt thereof or hydrates thereof.
    本发明公开了一种抗疟药剂,其中含有一种由式......表示的化合物: [其中 A1 代表可具有取代基的 3-吡啶基、可具有取代基的 6-喹啉基或类似基团;X1 代表由式-C(=O)-NH-或类似基团表示的基团;E 代表呋喃基、噻吩基或苯基; 但 A1 可具有一至三个取代基,E 具有两个取代基中的一个]或其盐或其合物。
查看更多